Empagliflozin, a sodium‐glucose cotransporter inhibitor enhancing mitochondrial action and cardioprotection in metabolic syndrome
Article in Journal of Cellular Physiology (May 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Journal of Cellular Physiology (May 2024)
Article in Aging (April 2024)
Preprint in medRxiv (April 2024)